Pascrate Inc. to Propose Home Syringe Method Fertility Kit "meeta" at Oki 2026 Autumn/Winter Proposal Trade Fair, Amidst Promotion of Preconception Care

Pascrate Inc. (Headquarters: Shinjuku-ku, Tokyo; Representative Director: Takaaki Iihara) will participate in the "Oki 2026 Autumn/Winter Proposal Trade Fair" to be held at the Tokyo Distribution Center on June 16 (Tue.) and 17 (Wed.), 2026.

This trade fair is by invitation only for industry-related professionals. Numerous new and proposed products for the upcoming fall season and beyond will be showcased, with over 100 manufacturers scheduled to exhibit.

Pascrate Inc. will display its "meeta" series of home syringe method fertility kits, which are registered as general medical devices, and its "Hanarila" series of nasal cleansing self-care products. The company will conduct product introductions and sales floor proposals for distribution partners.

Background

In recent years, interest in preconception care has been growing in Japan from the perspectives of addressing the declining birthrate and promoting future health.

Preconception care is the concept of engaging in health management and acquiring correct knowledge, regardless of gender, with future pregnancy and childbirth in mind.

The Children and Families Agency has formulated a "5-Year Plan for the Promotion of Preconception Care," promoting the dissemination of correct knowledge about sex and health, and the enhancement of consultation and support systems.

In addition to this social background, coupled with the increasing interest in women's health and self-care, retail industries, including drugstores, are expanding sales floor proposals for menstrual products, femcare products, and self-care items. There is also growing interest in creating environments where consumers can access health information and products tailored to their life stages, particularly within the fertility support category.

Pascrate Inc., in line with this trend, aims to provide information to distribution partners through the Oki 2026 Autumn/Winter Proposal Trade Fair, thereby increasing awareness of the fertility support category and promoting sales floor proposals.

Source: Children and Families Agency "5-Year Plan for the Promotion of Preconception Care (Outline)"

■Syringe Method Kit "meeta"


Home Syringe Method Fertility Kit "meeta 3-count"

"meeta" is a home syringe method fertility kit registered as a general medical device.

It is developed as a product in the increasingly popular fertility support category and is designed for home use under the supervision of a physician.

A key feature is its design, which considers the physique of Japanese women and simplifies the usage procedure, thereby reducing the preparation burden after purchase.

【Baby Life Lab Official Website】

https://babylife-lab.com/

Oki 2026 Autumn/Winter Proposal Trade Fair Overview

Dates: June 16 (Tue.) and 17 (Wed.), 2026
Venue: Tokyo Distribution Center (TRC)
Organizer: Oki Corporation *Participation is limited to invited companies. Not open to the general public.

Company Profile (Pascrate Inc.)

Headquarters Address: Kintetsu Shinjuku Gyoen Bldg. 9F, 1-8-4 Shinjuku, Shinjuku-ku, Tokyo
Established: November 25, 2008
Capital: ¥10,000,000
Representative: Takaaki Iihara, Representative Director
Business Activities: Planning, development, and sales of healthcare products; owned media business; SES business; human resource dispatch business; online school business
Medical Device Approvals: Class III Marketing and Sales of Medical Devices 13B3X10286 / Medical Device Manufacturing 13BZ201388

【Customer Inquiries】

Pascrate Inc.
Healthcare Business Division Customer Support
TEL (Toll-Free): 0120-905-147
E-mail: info@babylife-lab.com